Successful integration of newborn genetic testing into UK routine screening using prospective consent to determine eligibility for clinical trials
{{output}}
Objective: INGR1D (INvestigating Genetic Risk for type 1 Diabetes) was a type 1 diabetes (T1D) genetic screening study established to identify participants for a primary prevention trial (POInT, Primary Oral Insulin Trial). ... ...
